Preliminary in vitro studies using the canine prostate adenocarcinoma cell line CT1258 show mild doxorubicin resistance, high metabolic activity, and the expression of the alpha-6 integrin that characterizes tumor cells with stem-like characteristics. The gene discussed is ITGA6; the disease is prostate adenocarcinoma.